Dra. Silvia Neciosup (Perú) - SABCS 2024 [1]
San Antonio Breast Cancer Symposium (SABCS 2024)
Dra. Silvia Neciosup (Perú) - NATALEE- Eficacia & Reducción de dosis
Impact of ribociclib dose reduction on efficacy in patients with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2-) early breast cancer (EBC) in NATALEE
FA-11324977